157
Views
23
CrossRef citations to date
0
Altmetric
Clinical Focus: Urological Disorders

Diagnosis and Management of Urothelial Carcinoma of the Bladder

, MD & , MD
Pages 43-55 | Published online: 13 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Paola Valeria Marchese, Veronica Mollica, Elisa Tassinari, Dario De Biase, Francesca Giunchi, Andrea Marchetti, Matteo Rosellini, Michelangelo Fiorentino & Francesco Massari. (2022) Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers. Expert Review of Molecular Diagnostics 22:11, pages 997-1008.
Read now
Yi Gu*Jie Zeng*Yixin Zou, Chang Liu, Hongjuan Fu & Hui Chang. (2022) Folate Intake and Risk of Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Epidemiological Studies. Nutrition and Cancer 74:5, pages 1593-1605.
Read now
Michail Alevizakos & Joaquim Bellmunt. (2022) Adjuvant immunotherapy for muscle-invasive urothelial carcinoma of the bladder. Expert Review of Anticancer Therapy 22:3, pages 259-267.
Read now
Rositsa Mihaylova, Aleksandar Shkondrov, Denitsa Aluani, Iliana Ionkova, Virginia Tzankova & Ilina Krasteva. (2021) In vitro antitumour and immunomodulating activity of saponins from Astragalus glycyphyllos . Biotechnology & Biotechnological Equipment 35:1, pages 1948-1955.
Read now
P. A. Oliveira, R. M. Gil da Costa, C. Vasconcelos-Nóbrega, R. Arantes-Rodrigues & R. Pinto-Leite. (2016) Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery. Expert Opinion on Drug Discovery 11:6, pages 599-607.
Read now
Paula A Oliveira, Regina Arantes-Rodrigues & Carmen Vasconcelos-Nóbrega. (2014) Animal models of urinary bladder cancer and their application to novel drug discovery. Expert Opinion on Drug Discovery 9:5, pages 485-503.
Read now

Articles from other publishers (17)

Jing Jin, Junlong Li, Chao Peng, Jiajun Chen, Gang Xu & Shouhua Pan. (2023) Case report: durable complete response to pembrolizumab plus lenvatinib in a metastatic upper tract urothelial carcinoma patient with high tumor mutational burden and an immune-active tumor microenvironment. Anti-Cancer Drugs 34:6, pages 797-802.
Crossref
Tanjot Saini, Sundeep Bekal & Andrew D Liman. (2023) Lymphangitic Carcinomatosis of Possible Urothelial Origin. Cureus.
Crossref
Thiago Guimarães, Hugo Pinheiro, João Pimentel, Hermínia Pereira & Luís Campos Pinheiro. (2022) An Unexpected and Unpredictable Emergence of Muscle-Invasive Bladder Cancer in a Patient Successfully Treated With Nivolumab for Small-Cell Bladder Cancer. Cureus.
Crossref
Andrea B. Apolo, Pavlos Msaouel, Scot Niglio, Nicholas Simon, Elias Chandran, Deborah Maskens, Gabriela Perez, Karla V. Ballman & Chana Weinstock. (2022) Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers. American Society of Clinical Oncology Educational Book:42, pages 311-326.
Crossref
Cláudia Martins-Lima, Vera Miranda-Gonçalves, João Lobo, Vera Constâncio, Pedro Leite-Silva, Catarina Guimarães-Teixeira, Sara Monteiro-Reis, José Pedro Sequeira, Mariana Cantante, Céline S. Gonçalves, Bruno M. Costa, Rui Henrique & Carmen Jerónimo. (2022) Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression. Cellular Oncology 45:1, pages 135-149.
Crossref
Juliette M Kassas, Julia V Fiuk & Carol A Brenner. (2021) Primary Small Cell Carcinoma of the Bladder. Cureus.
Crossref
Mingshan Li, Yixiang Wang, Yili Liu, Xiling Zhang, Jie Liu & Ping Wang. (2019) Low Expression of hsa_circ_0018069 in Human Bladder Cancer and Its Clinical Significance. BioMed Research International 2019, pages 1-9.
Crossref
Wei Lu, Yanjun Wang, Yonghong Li, Yun Cao, Hui Han & Fangjian Zhou. (2017) Sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation of the ureter: A case report and review of the literature. Oncology Letters 13:3, pages 1331-1337.
Crossref
Boaz Kurtis, Jian Zhuge, Caroline Ojaimi, Fei Ye, Dongming Cai, David Zhang, John T. Fallon & Minghao Zhong. (2016) Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications. Annals of Diagnostic Pathology 21, pages 7-11.
Crossref
Ahmed Haddad, Yair Lotan & Arthur I. Sagalowsky. 2015. Bladder cancer. Bladder cancer 212 220 .
Z. M. Lisowski, T. S. Mair & D. Fews. (2015) Transitional cell carcinoma of the urinary bladder in a 12-year-old Belgian Warmblood gelding. Equine Veterinary Education 27:7, pages e20-e24.
Crossref
D. W. Knapp, J. A. Ramos-Vara, G. E. Moore, D. Dhawan, P. L. Bonney & K. E. Young. (2014) Urinary Bladder Cancer in Dogs, a Naturally Occurring Model for Cancer Biology and Drug Development. ILAR Journal 55:1, pages 100-118.
Crossref
Shao-Kuan Chen, Chih-Ang Chung, Yu-Che Cheng, Chi-Jung Huang, Ruoh-Chyu Ruaan, Wen-Yih Chen, Chuan Li, Chia-Wen Tsao, Wei-Wen Hu & Chih-Cheng Chien. (2014) Hydrostatic pressure enhances mitomycin C induced apoptosis in urothelial carcinoma cells. Urologic Oncology: Seminars and Original Investigations 32:1, pages 26.e17-26.e24.
Crossref
Benjamin R. Kipp & Kevin C. Halling. 2014. Molecular Diagnostics. Molecular Diagnostics 3 13 .
Deborah W. Knapp, Wendy A. Peer, Abass Conteh, Alfred R. Diggs, Bruce R. Cooper, Nita W. Glickman, Patty L. Bonney, Jane C. Stewart, Lawrence T. Glickman & Angus S. Murphy. (2013) Detection of herbicides in the urine of pet dogs following home lawn chemical application. Science of The Total Environment 456-457, pages 34-41.
Crossref
Deepika Dhawan, José A. Ramos-Vara, James F. Naughton, Liang Cheng, Philip S. Low, Ryan Rothenbuhler, Christopher P. Leamon, Nikki Parker, Patrick J. Klein, Iontcho R. Vlahov, Joseph A. Reddy, Michael Koch, Linda Murphy, Lindsey M. Fourez, Jane C. Stewart & Deborah W. Knapp. (2013) Targeting Folate Receptors to Treat Invasive Urinary Bladder Cancer. Cancer Research 73:2, pages 875-884.
Crossref
Prakash Kulkarni, Takumi Shiraishi, Krithika Rajagopalan, Robert Kim, Steven M. Mooney & Robert H. Getzenberg. (2012) Cancer/testis antigens and urological malignancies. Nature Reviews Urology 9:7, pages 386-396.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.